The specific aims of this study were to assess the effect of Escin alone and in combination with chemotherapy on pancreatic cancer cell survival and to examine whether this effect is associated with downregulation of the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.